Recurrent Merkel Cell Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01101 | Capecitabine | 1 | Withdrawn | 1 |
DB05759 | Cixutumumab | 1 | Completed | 1 |
DB12250 | Cixutumumab | 1 | Completed | 1 |
DB01590 | Everolimus | 1 | Completed | 1 |
DB00104 | Octreotide | 1 | Completed | 1 |
DB00853 | Temozolomide | 1 | Withdrawn | 1 |
DB07232 | Veliparib | 1 | Withdrawn | 1 |
DB00041 | Aldesleukin | 1 / 2 | Terminated | 1 |
DB14999 | Human interferon beta | 1 / 2 | Terminated | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Completed | 1 |